Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Lithuania’s official medicines laboratory’s functions, tasks and perspectives in prevention of lithuania’s pharmaceutical market from rejected medicines and pharmaceutical substances

  • At: 2005 FIP Congress in Cairo (Egypt)
  • Type: Poster
  • By: JAKIMAVICIUS (State medicines control agency, Kaunas, Lithuania)
  • Co-author(s): Mockute, Roma (State medicines control agency, VILNIUS, Lithuania)
    Jakimavicius, Mantas (State medicines control agency, VILNIUS, Lithuania)
    Juzenas, Martynas (Kaunas university of medicine, KAUNAS, Lithuania)
  • Abstract:

    Aims:

    This work involves the activity of LT-OMCL in 2001-2003. The main questions are:

    » Does LT-OMCL fully perform its functions, which are indicated in its official regulations?

    » How does LT-OMCL prevent Lithuania’s pharmaceutical market from rejected medicines and pharmaceutical substances?

    » Which drug defects were found?

    » What are..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses